Sector ratings Neurocrine Biosciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 11/04/2026 am IST			5-day change	1st Jan Change
128.89 ^USD	-2.09%		-2.06%	-9.12%

08/04	Health Care Up as Trump Administration Boosts Medicare Rate Proposal -- Health Care Roundup	DJ
07/04	Soleno withdraws EU rare disease drug application ahead of Neurocrine takeover	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NEUROCRINE BIOSCIENCES, INC.	1.29TCr		BBB
ELI LILLY AND COMPANY	84TCr		A
JOHNSON & JOHNSON	57TCr		BBB
ABBVIE INC.	37TCr		AA
ROCHE HOLDING AG	32TCr		AA			-		-
ASTRAZENECA PLC	32TCr		A
MERCK & CO., INC.	30TCr		A
NOVARTIS AG	29TCr		AAA
AMGEN INC.	19TCr		A
GILEAD SCIENCES, INC.	17TCr		AA
NOVO NORDISK A/S	17TCr		A
BRISTOL-MYERS SQUIBB COMPANY	12TCr		A
GSK PLC	12TCr		AA
SANOFI	11TCr		AA
VERTEX PHARMACEUTICALS INCORPORATED	11TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	8.97TCr		AA
ALLERGAN PLC	6.37TCr	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.69TCr		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.54TCr		AA
BAYER AG	4.63TCr		AA
Average	21.66TCr		AA
Weighted average by Cap.			AA